Literature DB >> 10953206

Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase.

J Rudolf1, M Grond, S Schmülling, M Neveling, W Heiss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953206     DOI: 10.1212/wnl.55.4.599

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications.

Authors:  Cumara B O'Carroll; Maria I Aguilar
Journal:  Neurohospitalist       Date:  2015-07

2.  Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator.

Authors:  Muhammad Khalid; Majd Kanaa; Yazan Alkawaleet; Muhammad Talha Ayub
Journal:  Cureus       Date:  2018-03-29

3.  Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.

Authors:  S T Engelter; F Fluri; C Buitrago-Téllez; S Marsch; A J Steck; S Rüegg; P A Lyrer
Journal:  J Neurol       Date:  2005-09-27       Impact factor: 4.849

Review 4.  Management of acute ischaemic stroke in the elderly: tolerability of thrombolytics.

Authors:  D Tanne; D Turgeman; Y Adler
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.

Authors:  Daniel J Miller; Jennifer R Simpson; Brian Silver
Journal:  Neurohospitalist       Date:  2011-07

Review 6.  Drug-induced angioedema without urticaria.

Authors:  A Agostoni; M Cicardi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

7.  Onset of Orolingual Angioedema After Treatment of Acute Brain Ischemia with Alteplase Depends on the Site of Brain Ischemia: A Meta-analysis.

Authors:  Josef Yayan
Journal:  N Am J Med Sci       Date:  2013-10

8.  Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis.

Authors:  In-Serk Park; A-Hyun Cho; Seung-Jae Lee; Joong-Seok Kim; Kwang-Soo Lee; Yeong-In Kim
Journal:  J Clin Neurol       Date:  2008-03-20       Impact factor: 3.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.